EMJ Respiratory 12 [Supplement 2] . 2024

In this issue

Today, asthma and COPD affect more than 550 million people worldwide, representing a huge and growing burden on patients, healthcare systems, and the planet. In an interview with EMJ, chronic respiratory disease specialists Simon Couillard, Professor at the University of Sherbrooke, Canada; Richard Russell, Professor at King’s College London, UK; and Arzu Yorgancioglu, Professor at Celal Bayar University, Manisa, Turkey, provide unique insights into the benefits of early intervention for asthma and COPD on both patient outcomes and the environment.